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We discuss a patient who had poorly diﬀerentiated HCC with pyrexia and high CRP in laboratory data, which are not commonly
observed in the usual HCC. A 50-year-old man with a history of liver dysfunction was admitted with a chief complaint of a
prolonged fever and general fatigue. Preoperative diagnosis was HCC with portal vein tumor thrombus. Posterior segmentectomy
of the liver and thrombectomy was performed. Rapid tumor recurrence occurred after surgery, and he died 79 days after the
operation. Immunohistochemical stain of HCC in this patient revealed the production of proinﬂammatory cytokine, interleukin-
8 (IL-8). IL-8 production may have contributed to the high fever, high inﬂammatory reaction, and poor prognosis in this case.
Copyright © 2009 Norifumi Harimoto et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1.Introduction
Hepatocellular carcinoma (HCC) is a common malignancy
and is now one of the major causes of death in Asian
countries [1]. Generally, HCCs are often asymptomatic,
but fatigue, abdominal distention and low-grade fever were
sometimes observed because of poor liver function. How-
ever, fever as a primary symptom in HCC is relatively rare.
Additionally,highCRPinlaboratoryresultsisalsorare.HCC
with pyrexia has been reported only in a few studies [2–4]
and the cause of pyrexia has remained unknown.
Recently, increased production of proinﬂammatory
cytokines and chemokines, such as interleukin-1 α (IL-1α),
interleukin-1 β (IL-1β), interleukin-6(IL-6), interleukin-
8(IL-8), and tumor necrosis factor-α (TNF-α)h a v eb e e n
reportedtobefebriferousinacuteandchronicinﬂammatory
disease [5, 6]. These cytokines are produced by immune cells
including various populations of lymphocytes macrophages
and other cells. Among the proinﬂammatory cytokines, IL-
8 is a neutrophil chemotactic factor and involved in tumor
proliferation and migration, angiogenesis in malignant
tumors. This is often accompanied by rapid growth and poor
prognosis in malignant tumors [7–13].
We herein discuss a case of HCC accompanied by
prolonged spiking fevers, which disappeared after tumor
resection.ImmunohistochemicalstainofHCCinthispatient
revealed the production of IL-8.
2.CaseReport
A 50-year-old man with a history of liver dysfunction was
admitted to Iizuka Hospital with the chief complaint of
a prolonged fever and general fatigue in October, 2005.
T h et e m p e r a t u r ew a so v e r3 8 ◦C. Hematological laboratory
data on admission were as follows: WBC 9670/μl, ALP
552U/l, CRP 16.7mg/dl, and AFP 11.1ng/mL. HBs-antigen
was positive (Table 1). A Computed tomography (CT)
showed a peripherally enhanced low density mass 7.5cm in
diameter, which located in segment 6 in the right lobe of
the liver (Figure 1(a)). The tumor was accompanied with
tumor thrombus to the posterior branch of portal vein
(Figure 1(b)). Celiac angiography showed this lesion was
hypervascular (Figure 1(c)) and portal vein tumor thrombus
in posterior segment was observed in the portal phase
(Figure 1(d)).
Biopsy was not done in this case because of danger
of tumor seeding. Patients have chronic hepatitis B and
then tumor was hypervascular and accompanied with portal
thrombus, which is the feature of HCC, therefore a preoper-2 HPB Surgery
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Figure 1: (a) A Computed tomography (CT) showed a peripherally enhanced low density mass 7.5cm in diameter, which located in
segment 6 in the right lobe of the liver. (b) Tumor was accompanied with tumor thrombus to the posterior branch of portal vein. (c)
Celiac angiography showed this lesion to be hypervascular. (d) Portal vein tumor thrombus in posterior segment was observed in portal
phase of SMA angiography.
(a) (b)
Figure 2: (a) Intraoperative ﬁndings revealed tumor was white and intrahepatic metastasis was observed. (b) On cut section, tumor was
white and contained coagulation and necrosis. Portal vein tumor thrombus in segment 6 of the liver was observed (arrow heads).
ative diagnosis was made as HCC with portal vein thrombus
and nonsteroidal anti-inﬂammatory drugs were used to
reduce the fever. Enough explanation was performed to the
patient and informed consent for operation was obtained.
Hepatic resection was conducted in November, 2005. The
tumor was white and intrahepatic metastasis was observed
(Figure 2(a)). A single nodule of disseminated cancer cells
was found near the posterior segment on the abdominal
wall during the operation. Posterior segmentectomy of the
liver and thrombectomy including the dissemination was
performed.Onthecutsection,thetumorwaswhiteandcon-
tained coagulation and necrosis (Figure 2(b)). HistologicalHPB Surgery 3
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Figure 3: (a) Histological ﬁndings revealed poorly diﬀerentiated HCC with trabecular pattern. Neutrophil inﬁltration in the tumor was
observed. (b) Immunohistochemically, paraﬃn section of tumor tissue stained positive for IL-8 (arrow heads).
Table 1: Laboratory data in this patient. (normal range).
WBC 9670/μL (3500–9500)
Neut 71.8% (40–74)
Lym 21.5% (20–74)
Hb 13.2g/dl (12.7–17.1)
Plt 34.0 ×104 /μL( 1 3 .8 ×104–33.5 ×104)
PT 77.6% (86–130)
APTT 41.9sec (24.8–36.5)
TP 7.1g/dl (6.7–8.3)
Alb 2.6g/dl (4.0–5.0)
T.Bil 0.4mg/dl (0.3–1.2)
D.Bil 0.1mg/dl (0–0.4)
AST 38U/l (13–33)
ALT 23U/l (6–30)
LDH 330U/l (119–229)
ALP 552U/l (115–359)
γGTP 79U/l (10–47)
ChE 30U/l (214–466)
TC 97mg/dl (128–219)
TG 48mg/dl (30–149)
Amy 111U/l (42–132)
BUN 11mg/dl (8–22)
Cr 0.6mg/dl (0.6–1.1)
FBS 103mg/dl (69–109)
CRP 16.7mg/dl (<0.2)
ICGR15 11.5% (<10)
AFP 11.1ng/mL (<20)
PIVKA-II 16mAU/mL (<40)
CEA 1.1ng/mL (<5)
CA19-9 13.5U/mL (<37)
HBs-Ag HBe-Ag (+)
HBe-Ab HCV-Ab (−)4 HPB Surgery
ﬁndings revealed poorly diﬀerentiated HCC with a trabec-
ular pattern. Multiple tumors of intrahepatic metastases and
portal vein invasion were observed. Neutrophil inﬁltration
in the tumor was observed (Figure 3(a)). The noncancer-
ous liver tissue showed a moderate chronic inﬂammatory
inﬁltrate in the ﬁbrous stroma, diagnosed as liver ﬁbrosis.
Immunohistochemical stain of IL-8 was performed with
paraﬃn embedded sections of liver tissue using mouse mon-
oclonal antibody at dilutions of 1 : 100 (Assay designs, Ann
Arbor, USA). Immunohistochemical staining was described
previously [14]. The subsequent reaction was performed by
the peroxidase labeled streptavidin-biotin technique using
Histoﬁne SAB-PO kit (Nichirei, Tokyo, Japan). IL-8 was
observed in the cytoplasm of cancer cells (Figure 3(b)).
After the tumor resection, fever disappeared and CRP
dropped gradually from 16.7 to 2.7, but the patient had
recurrence with multiple liver metastasis and pleuritis car-
cinomatosa and died on February 2, 2006, 79 days after the
operation.
3. Discussion
In 1991, Okuda et al. [2] reported ﬁve patients with HCC
and pyrexia, for an incidence of less than 1%, in Japan. He
also mentioned that very poorly diﬀerentiated sarcomatoid
HCC may frequently appear with pyrexia and leukocytosis
mimicking liver abscess. In 1995, Hayashi et al. [3]r e p o r t e d
HCC with pyrexia. Histological examination revealed poorly
diﬀerentiated HCC with sarcomatoid degeneration. Labo-
ratory data revealed high CRP. Nevertheless, in both case
reports, the mechanism of a fever was not revealed. In our
case, the sarcomatoid change of the cancer cell was not
detected, only poorly diﬀerentiated HCC.
It is well known that cancer cells produce humoral
factors and cause the “paraneoplastic syndrome”. Among
the clinical symptoms and laboratory data, fever and high
CRP, which is not commonly observed in the patients
with HCC, is suspected to be due to humoral factors,
especially inﬂammatory cytokine. IL-8 is a proinﬂammatory
cytokine whose principal role in infection and inﬂammation
appears to be the recruitment and activation of circulating
and tissue neutrophils to the site of tissue damage. It has
been demonstrated that IL-8 is produced by a wide variety
of cell types in vitro, including endothelium, monocytes,
eosinophils, astrocytes and keratinocytes. In sepsis patients,
for example, IL-8 concentrations have been reported as
being markedly elevated at diagnosis and remaining high
during the course of the illness [15]. Patients with pyrexia
is suﬀering from a high fever and body weight loss. This
symptom is induced by many humoral factors, including
IL1β,I L - 6 ,I L 8a n dT N F α. Zampronio AR reported that IL-
8 induced fever by prostaglandin independent mechanism
[16]. Additionally, IL-8 was correlated with weight loss in
pancreatic cancer [17]. IL-8 resulted in a dose-dependent
increase of CRP [18], a decrease in the production of
transferring and prealbumin. Therefore, IL-8 is related to
pyrexia in parts, not all.
In other cancer, Interleukin-8 Producing Malignant
Fibrous Histiocytoma with Prolonged Fever was reported
[19]. We examined by immunohistochemical staining of IL-
8 and tumor tissue stained positive for IL-8 in this case.
Akiba et al. [7] reported that a high IL-8 level in HCC
had a signiﬁcantly higher frequency of portal vein invasion
and venous invasion and bile duct invasion. In vitro, IL-
8 production accelerated the proliferation of endothelial
cells. Tachibana et al. [9]r e p o r t e dI L - 8p r o d u c t i o nw a s
enhanced progressively with escalating severity of hepatitis
and the development of HCC and the level of IL-8 were
signiﬁcantly increased in patients with advanced HCC with
distant metastasis, and then this leads to poor prognosis.
Ren et al. reported serum IL-8 level was correlated with
tumor size and tumor stage, and then IL-8 level was a
signiﬁcant prognostic factor in terms of disease-free survival
and overall survival [13]. Additionally, elevated IL-8 levels
in the drainage vein of colorectal cancer are related to the
occurrence of hepatic metastasis [10]. This case presented
portal vein tumor thrombus, bile duct invasion, intrahepatic
metastasis,peritonealdissemination,earlytumorrecurrence,
rapid tumor regrowth and ﬁnally a poor prognosis. In fact,
all patients with IL-8 production do not have a high fever,
the serum concentration of IL-8 or the degree of neutrophil
inﬁltration will be concerned with pyrexia.
In many cancers suchas esophageal cancer, gastric cancer
and colorectal cancer, serum CRP was known as a prognostic
indicator [20–23]. In particular, some reported that serum
CRP levels indicated a poor prognosis in HCC patients
and portal vein invasion was signiﬁcantly higher in the
serum CRP-positive group [24, 25]. According to the in
vitro previous studies, cultured HCC can produce CRP that
is regulated in part by proinﬂammatory cytokines, such
as IL-6, IL-8 and TNF-α [18, 26, 27]. Among the many
proinﬂammatory cytokines, recent report IL-6 mediates cell
cycle arrest in hepatocellular carcinoma through a STAT 3-
dependent pathway [28]. Adverse eﬀect may occur according
to the type of cytokines. HCC produce proinﬂammatory
cytokines such as IL-8 by autocrine or paracrine, which
lead to CRP production and inﬂammatory cascade or tumor
progression.
In this report we discussed a patient who had poorly
diﬀerentiated HCC with pyrexia and high CRP. The patient
had surgical resection, but rapid tumor recurrence occurred.
IL-8 production was histologically revealed in this case and
may have contributed to the high fever, high inﬂammatory
reaction and poor prognosis.
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